CLINICAL_TRIALS
trial_result
· 2021-04-27
Clinical Trial Update: Study of Efficacy and Safety of LOU064 in Inadequately Controlled Asthma Patients [Phase 2]
Summary
Phase 2 study evaluating LOU064 for inadequately controlled asthma was terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 2 | Status: TERMINATED | Results posted: 2021-04-27